*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter - as a primary diagnosis code | T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 4.91 | |
| Readmission Rate (%) | 21.78 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 71,748 | |
| Total Hospitalizations with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 16 | |
| DRG Share of Total Hospitalizations | 0.22 | |
| % of Total ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter in DRG | 53.33 | |
| Avg LOS at DRG | 2.93 | |
| Avg LOS with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 2.94 | |
| Readmission Rate at DRG | 33.86 | |
| Readmission Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | NA | |
| Unplanned Readmission Rate at DRG | 10.34 | |
| Unplanned Readmission Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | NA | |
| Total Medicare payments at DRG | $313,351,773 | |
| Total Medicare payments with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $53,375 | |
| Total Medicare payment per Day at DRG | $1,489 | |
| Total Medicare payment per Day with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $1,136 | |
| Total Medicare payment per Hospitalization at DRG | $4,367 | |
| Total Medicare payment per Hospitalization with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $3,336 | |
| Total Medicare Charges at DRG | $1,750,048,705 | |
| Total Medicare Charges with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $432,910 | |
| Avg Charges at DRG | $24,392 | |
| Avg Charges with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $27,057 | |
| Mortality Rate at DRG | 0.22 | |
| Mortality Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | NA | |
| SNF Discharge Rate at DRG | 7.61 | |
| SNF Discharge Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | NA | |
| Home Discharge Rate at DRG | 51.88 | |
| Home Discharge Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 312: SYNCOPE AND COLLAPSE | DRG 093: OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 122,730 | ||||
| Total Hospitalizations with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 348 | ||||
| DRG Share of Total Hospitalizations | 0.37 | ||||
| % of Total ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter in DRG | 9.44 | ||||
| Avg LOS at DRG | 7.61 | ||||
| Avg LOS with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 3.43 | ||||
| Readmission Rate at DRG | 21.31 | ||||
| Readmission Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 20.0 | ||||
| Unplanned Readmission Rate at DRG | 14.13 | ||||
| Unplanned Readmission Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 11.82 | ||||
| Total Medicare payments at DRG | $1,397,885,220 | ||||
| Total Medicare payments with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $1,895,359 | ||||
| Total Medicare payment per Day at DRG | $1,497 | ||||
| Total Medicare payment per Day with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $1,586 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,390 | ||||
| Total Medicare payment per Hospitalization with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $5,446 | ||||
| Total Medicare Charges at DRG | $4,175,290,309 | ||||
| Total Medicare Charges with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $9,535,461 | ||||
| Avg Charges at DRG | $34,020 | ||||
| Avg Charges with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $27,401 | ||||
| Mortality Rate at DRG | 0.28 | ||||
| Mortality Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 21.64 | ||||
| SNF Discharge Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 32.47 | ||||
| Home Discharge Rate at DRG | 28.06 | ||||
| Home Discharge Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 36.49 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 551: MEDICAL BACK PROBLEMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 365,119 | ||||
| Total Hospitalizations with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 103 | ||||
| DRG Share of Total Hospitalizations | 1.11 | ||||
| % of Total ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter in DRG | 2.8 | ||||
| Avg LOS at DRG | 5.91 | ||||
| Avg LOS with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 4.51 | ||||
| Readmission Rate at DRG | 27.73 | ||||
| Readmission Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 24.47 | ||||
| Unplanned Readmission Rate at DRG | 20.3 | ||||
| Unplanned Readmission Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 14.89 | ||||
| Total Medicare payments at DRG | $3,552,910,533 | ||||
| Total Medicare payments with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $900,671 | ||||
| Total Medicare payment per Day at DRG | $1,646 | ||||
| Total Medicare payment per Day with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $1,937 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,731 | ||||
| Total Medicare payment per Hospitalization with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $8,744 | ||||
| Total Medicare Charges at DRG | $16,860,985,198 | ||||
| Total Medicare Charges with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $3,521,083 | ||||
| Avg Charges at DRG | $46,179 | ||||
| Avg Charges with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $34,185 | ||||
| Mortality Rate at DRG | 5.06 | ||||
| Mortality Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 28.7 | ||||
| SNF Discharge Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 32.04 | ||||
| Home Discharge Rate at DRG | 32.16 | ||||
| Home Discharge Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 31.07 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 947: SIGNS AND SYMPTOMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 215,355 | ||||
| Total Hospitalizations with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 67 | ||||
| DRG Share of Total Hospitalizations | 0.66 | ||||
| % of Total ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter in DRG | 1.82 | ||||
| Avg LOS at DRG | 3.28 | ||||
| Avg LOS with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 5.1 | ||||
| Readmission Rate at DRG | 16.7 | ||||
| Readmission Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 16.67 | ||||
| Unplanned Readmission Rate at DRG | 4.47 | ||||
| Unplanned Readmission Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | NA | ||||
| Total Medicare payments at DRG | $5,278,830,730 | ||||
| Total Medicare payments with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $1,686,065 | ||||
| Total Medicare payment per Day at DRG | $7,462 | ||||
| Total Medicare payment per Day with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $4,930 | ||||
| Total Medicare payment per Hospitalization at DRG | $24,512 | ||||
| Total Medicare payment per Hospitalization with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $25,165 | ||||
| Total Medicare Charges at DRG | $25,567,888,167 | ||||
| Total Medicare Charges with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $8,544,868 | ||||
| Avg Charges at DRG | $118,724 | ||||
| Avg Charges with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $127,535 | ||||
| Mortality Rate at DRG | 0.03 | ||||
| Mortality Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 15.71 | ||||
| SNF Discharge Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 32.84 | ||||
| Home Discharge Rate at DRG | 51.89 | ||||
| Home Discharge Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 38.81 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | DRG 459: SPINAL FUSION EXCEPT CERVICAL WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 071: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 539,642 | ||||
| Total Hospitalizations with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 48 | ||||
| DRG Share of Total Hospitalizations | 1.64 | ||||
| % of Total ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter in DRG | 1.3 | ||||
| Avg LOS at DRG | 6.42 | ||||
| Avg LOS with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 4.15 | ||||
| Readmission Rate at DRG | 26.55 | ||||
| Readmission Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | NA | ||||
| Unplanned Readmission Rate at DRG | 20.01 | ||||
| Unplanned Readmission Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | NA | ||||
| Total Medicare payments at DRG | $5,267,842,463 | ||||
| Total Medicare payments with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $375,712 | ||||
| Total Medicare payment per Day at DRG | $1,520 | ||||
| Total Medicare payment per Day with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $1,888 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,762 | ||||
| Total Medicare payment per Hospitalization with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $7,827 | ||||
| Total Medicare Charges at DRG | $25,503,568,329 | ||||
| Total Medicare Charges with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $1,578,536 | ||||
| Avg Charges at DRG | $47,260 | ||||
| Avg Charges with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | $32,886 | ||||
| Mortality Rate at DRG | 5.62 | ||||
| Mortality Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 19.26 | ||||
| SNF Discharge Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | NA | ||||
| Home Discharge Rate at DRG | 39.65 | ||||
| Home Discharge Rate with ICD T481X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter | 31.25 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| OSF SAINT FRANCIS MEDICAL CENTER | 530 NE GLEN OAK AVE | PEORIA | IL | 61637 | 18 |
| CENTRA VIRGINIA BAPTIST HOSPITAL | 3300 RIVERMONT AVE | LYNCHBURG | VA | 24503 | 18 |
| ST. JOHN MEDICAL CENTER | 1923 S UTICA AVE | TULSA | OK | 74104 | 15 |